|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risk matrix: an approach for identifying, assessing, and ranking program risks 显示文摘 | Garvey P R Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，22，1： | 1 |
| 2 | Risk matrix: an approach for identifying, assessing, and ranking program risks 显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Journal of Logistics1998，，25： | 1 |
| 3 | Risk matrix:an approach for identifying,assessing and ranking program risks显示文摘 | Paul R Garve YPR Lansdowne ZF | | 0，，1： | 1 |
| 4 | Risk matrix: an approach for identifying ,assessing, and ranking program risk显示文摘 | Garvey P R Lansdowne Z F | 1998 | Air force Journal of Logistics1998，22，1： | 1 |
| 5 | Risk matrix:an approach for identifying,assessing,and ranking program risks显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，25，： | 1 |
| 6 | Risk matrix: an approach for identifying, assessing, and ranking program risks 显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，25，2： | 1 |
| 7 | Risk matrix:an approach for identifying,assessing,and ranking program risks显示文摘 | Paul R Garvey PR Lansdowne ZF | 1998 | Air Force Journal of Logistics1998，22，1： | 1 |
| 8 | Steroid hormone receptor expression in male breast cancer显示文摘 | Murphy C E Carder P J Lansdown M R | 2006 | Eur J Surg Oncol2006，32，： | 1 |
| 9 | Risk Matrix:an Approach for Identifying,Assessing and Ranking Program Risks显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，，25： | 1 |
| 10 | Risk matrix: an approach for identifying, assessing and ranking program risks显示文摘 | PAUL R GARVEY P R LANSDOWNE Z F | 1998 | Air Force Journal of Logistics1998，22，1： | 1 |
| 11 | Risk matrix:an approach for identifying, assessing,and ranking program risks显示文摘 | PAUL R GARVEY P R LANSDOWNE Z F | 1998 | Air Force J Logis- tics1998，，25： | 1 |
| 12 | Nanoparticles drug delivery system or intravenous delivery of topoisomerase inhibitors 显示文摘 | Williams J Lansdown R Sweitzer R | 2003 | J Control Release2003，91，12： | 1 |
| 13 | Risk matrix: an approach for identifying, assessing, and ranking program risk显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air force Journal of Logistics1998，25，： | 1 |
| 14 | Risk matrix:an approach for identifying, assessing,and ranking program risks显示文摘 | Paul R Garvey PR Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，25，： | 1 |
| 15 | Risk matrix:an approach for identifying, assessing, and ranking program risks显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Journal of Logistics1998，，25： | 1 |
| 16 | Risk Matrix: An Approach for Identifying, Assessing, and Ranking Program Risks 显示文摘 | Garvey P R Lansdowne Z F | 1998 | AirForce Journal of Logisties1998，25，： | 1 |
| 17 | Risk matrix:An approach for identifying, assessing; and ranking program risks显示文摘 | Paul R Garvey P R Lansdowne Z F | 1998 | Air Force Journal of Logistics1998，，： | 1 |
| 18 | Risk matrix:An approach for identifying,assessing,and ranking program risks显示文摘 | PAUL R GARVEY P R LANSDOWNE Z F | 1998 | Air Force Journal of Logistics1998，25，： | 1 |
| 19 | Vascular endothelial growth factor(VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of Tamoxifen 显示文摘 | Carder PJ Downey S Forbes MA MacLennan K Allgar V Kaufman S Hallam S Bicknell R Walker JJ Cairnduff F Selby PJ Perren TJ Lansdown M Banks RE | 2000 | Cancer Res2000，60，11： | 1 |
| 20 | Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors显示文摘 | Williams J Lansdown R Sweitzer R | 2003 | J Control Release2003，91，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员